118719

About Astrid Roe

118719

IPO Comments to USPTO Regarding Withdrawal of Changes to Post Registration Response Deadlines

IPO Comments to USPTO Regarding Withdrawal of Changes to Post [...]

By Astrid Roe|2024-08-19T16:29:15-04:00August 19th, 2024|Testimony and Comments|Comments Off

Read More

IPO Comments to NIH Regarding Draft Intramural Research Program Policy: Promoting Equity Through Access Planning

IPO Comments to NIH Regarding Draft Intramural Research Program Policy: [...]

By Astrid Roe|2024-07-24T13:25:33-04:00July 22nd, 2024|Testimony and Comments|Comments Off

Read More

IPO Comments to CIPO Concerning Proposed Regulatory Amendments to the Patent Rules for Establishing Patent Term Adjustment

IPO Comments to CIPO Concerning Proposed Regulatory Amendments to the [...]

By Astrid Roe|2024-07-02T16:02:30-04:00June 28th, 2024|Testimony and Comments|Comments Off

Read More

IPO Comments to USPTO Regarding Setting and Adjusting Trademark Fees During Fiscal Year 2025

IPO Comments to USPTO Regarding Setting and Adjusting Trademark Fees [...]

By Astrid Roe|2024-05-29T09:21:26-04:00May 28th, 2024|Testimony and Comments|Comments Off

Read More

IPO Comments to USPTO on Expanding Opportunities to Appear Before the Patent Trial and Appeal Board

IPO Comments to USPTO on Expanding Opportunities to Appear Before [...]

By Astrid Roe|2024-05-21T14:36:52-04:00May 21st, 2024|Testimony and Comments|Comments Off

Read More

IPO Comments to USPTO on Motion to Amend Practice and Procedures in Trial Proceedings Under the AIA Before the PTAB

IPO Comments to USPTO on Motion to Amend Practice and [...]

By Astrid Roe|2024-05-03T13:53:24-04:00May 3rd, 2024|Testimony and Comments|Comments Off

Read More